Actinium Pharmaceuticals, Inc.
ATNM · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$38,243 | -$48,818 | -$33,017 | -$24,774 |
| Dep. & Amort. | $811 | $790 | $699 | $524 |
| Deferred Tax | $0 | $0 | $402 | -$1,547 |
| Stock-Based Comp. | $5,292 | $0 | $2,795 | $1,694 |
| Change in WC | -$932 | -$3,149 | $38,167 | $1,690 |
| Other Non-Cash | $0 | $3,842 | -$402 | $1,547 |
| Operating Cash Flow | -$33,072 | -$47,335 | $8,644 | -$20,866 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11 | -$153 | -$366 | -$133 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$11 | -$153 | -$366 | -$133 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$9 | -$4 | -$49 | -$85 |
| Stock Issued | $29,255 | $14,874 | $23,158 | $35,300 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $75 | $0 | $0 | $6 |
| Financing Cash Flow | $29,321 | $14,870 | $23,109 | $35,221 |
| Forex Effect | $0 | -$11 | $0 | $0 |
| Net Chg. in Cash | -$3,762 | -$32,629 | $31,387 | $14,222 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $76,990 | $109,306 | $78,221 | $63,999 |
| End Cash | $73,228 | $76,677 | $109,608 | $78,221 |
| Free Cash Flow | -$33,083 | -$47,488 | $8,278 | -$20,999 |